Navigation Links
AEterna Zentaris' Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia
Date:4/22/2008

QUEBEC CITY, April 22 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its partner, Spectrum Pharmaceuticals (NASDAQ: SPPI), released Phase 2b results for ozarelix, a luteinizing hormone-releasing hormone (LHRH) antagonist in benign prostatic hyperplasia (BPH).

Spectrum indicated that ozarelix demonstrated sufficient clinical activity to justify its continued development in BPH. Based on these results, Spectrum is planning to submit a protocol to the FDA for the next study of ozarelix in BPH.

"We are pleased that Spectrum is proceeding with plans for their upcoming study," stated Paul Blake, M.D., Senior Vice President and Chief Medical Officer of AEterna Zentaris. "AEterna Zentaris remains committed about the potential of LHRH antagonists for BPH, particularly for our lead candidate cetrorelix, which has produced robust and consistent findings in Phase 2 trials and is currently being evaluated in three multi-center Phase 3 trials in the United States, Canada and Europe." He said that results from the cetrorelix Phase 3 program are expected in the third quarter of 2009.

About Ozarelix and Partnerships

Ozarelix is an injectable fourth generation LHRH antagonist administered as an intramuscular injection. In August 2004, AEterna Zentaris granted Spectrum Pharmaceuticals an exclusive license to develop and market ozarelix for all potential indications in North America (inc
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia
2. AEterna Zentaris Announces Changes to its Management Team
3. AEterna Zentaris and Paladin Labs Complete Sale and Purchase of Miltefosine Rights
4. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
5. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
6. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
7. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
8. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
9. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
10. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
11. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2015)... 29, 2015  Caris Life Sciences® today announced ... Molecular Intelligence®, the company,s panomic, comprehensive tumor profiling ... several rare and difficult to treat gynecological cancers ... potential to improve patient outcomes. These studies were ... Society of Gynecologic Oncology (SGO) 2015 Annual Meeting ...
(Date:3/29/2015)... Texas , March 29, 2015 /PRNewswire/ ... presentation of important study data showing the ... in 1,599 gynecologic cancer samples. Using Caris ... profiling service, researchers identified expression of programmed ... cancers independent of histology while its ligand ...
(Date:3/27/2015)... 27, 2015 Earlier this year, the ... of hair regrowth in adult men and women with ... Norwood Hamilton classifications of IIa-V and Fitzpatrick Classification of ... by products that over-promise and under-deliver, FDA Clearance underscores ... and confidence among more than 80 million men and ...
(Date:3/27/2015)... , 27. März 2015  Peter Walter ... Biomedical Science für seine bahnbrechende Arbeit ausgewählt, ... Zellkompartimenten transportiert werden, sowie für die Entschlüsselung ... Reaktion auf Stress nutzen, der mit der ... ist Professor für Biochemie an der University ...
Breaking Biology Technology:Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 2Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 3Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 4Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 2Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 3Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 4Dr. Robert Leonard Applauds FDA Clearance of Capillus272Pro™ Hair Loss Laser Cap 2Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 2Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 3Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 4
... Uterine fibroids affect more than 30% of American women. ... require fibroid treatment . Uterine fibroids treatment ... cause pressure on other organs (such as the bladder), grow ... fibroids symptoms usually cause heavy or abnormal bleeding and discomfort, ...
... Pepscan Therapeutics Announces Establishment of Scientific Advisory Board -- LELYSTAD, The Netherlands, September 28, 2010 ... ... lpUnit=,PRN,; --> ... { var s = ,; var first_result; // Results are keyed by longUrl, so we need to ...
... to Push Scientific Search and Discovery to the... -- AMSTERDAM, September 28, 2010 ... ... --> ... s = ,; var first_result; // Results are keyed by longUrl, so we need to grab the ...
Cached Biology Technology:Dr. Ramin Mirhashemi, MD of Gynecological Oncology Associates Discusses Uterine Fibroid Treatment with da Vinci Robotic Hysterectomy Surgery 2Pepscan Therapeutics Announces Establishment of Scientific Advisory Board 2Pepscan Therapeutics Announces Establishment of Scientific Advisory Board 3Pepscan Therapeutics Announces Establishment of Scientific Advisory Board 4Pepscan Therapeutics Announces Establishment of Scientific Advisory Board 5Pepscan Therapeutics Announces Establishment of Scientific Advisory Board 6Pepscan Therapeutics Announces Establishment of Scientific Advisory Board 7Elsevier Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level 2Elsevier Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level 3Elsevier Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level 4Elsevier Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level 5Elsevier Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level 6Elsevier Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level 7Elsevier Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level 8Elsevier Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level 9Elsevier Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level 10
(Date:3/19/2015)... Conn. , March 19, 2015  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, announces ... in a news clip that aired this week on ... ) . In a segment "The Next Great ... wallet ,a new way to pay, and ,a really big ...
(Date:3/16/2015)... HANOVER, Germany , March 16, 2015 /PRNewswire/ ... DERMALOG Identification Systems GmbH will present groundbreaking innovations ... Hanover, Germany . ... DERMALOG,s latest biometric innovation is well at ... the next generation e-gate made in ...
(Date:3/11/2015)... , Mar. 11, 2015 Research and Markets ... of the "Access Control Market by Product, Application ... 2020" report to their offering. , ... expected to reach $10.4 billion by 2020, with an ... market report covers the products types such as contact ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2
... The world,s smallest species of snake, with adults averaging just ... Caribbean island of Barbados. The species -- which is ... rest comfortably on a U.S. quarter --was discovered by Blair ... his colleagues also are the discoverers of the world,s smallest ...
... last decade, childhood obesity has grown into an epidemic, ... recommendations that pediatricians check toddlers for elevated cholesterol. ... intervene. A study presented at a pediatric research ... as early as age two, when children reach a ...
... history of science and technology, there is an ... developments converge that make it possible to recognize ... biomechanics and astrobiology with more recent developments of ... now well established in the lexicon of modern ...
Cached Biology News:World's smallest snake found in Barbados 2World's smallest snake found in Barbados 32 years old -- a childhood obesity tipping point? 2The emerging scientific discipline of aeroecology 2
Immunogen: Purified native p24 from strain IIIB. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biotin d anti-mouse Tim-1...
Mouse monoclonal [MLM544] to cardiac Myosin light chain 1 ( Abpromise for all tested applications). entrezGeneID: 4634 SwissProtID: P08590...
Anti-20S proteasome subunits alpha 1, 2, 3, 5, 6 & 7, clone MCP231 Immunogen: Dinitrophenylated proteasomes Molecular Weight: 29 and 32 kDa....
Biology Products: